In a 34-year-old obese male with upper abdominal pain who is taking a proton pump inhibitor (PPI) for gastroesophageal reflux disease, a recent CT scan shows a 2.0 × 2.1 × 4.1 cm nodule in the posterior limb of the right adrenal gland; could this adrenal incidentaloma be causing his pain or is it unrelated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Adrenal Nodule is Almost Certainly Unrelated to His Pain

This 4.1 cm adrenal incidentaloma is extremely unlikely to be causing his upper abdominal pain, as adrenal masses—whether benign or malignant—are typically asymptomatic and discovered incidentally. His pain is far more likely related to his known gastroesophageal reflux disease or other upper GI pathology. 1

Why Adrenal Masses Don't Cause Pain

  • Adrenal incidentalomas are by definition asymptomatic masses found on imaging performed for unrelated reasons. 1 The fact that this was discovered on CT done for abdominal pain evaluation doesn't change its classification—it wasn't suspected clinically before imaging.

  • Pain is not a feature of adrenal adenomas, pheochromocytomas, or even most adrenocortical carcinomas unless there is hemorrhage, rapid expansion, or local invasion. 1 None of these acute processes are suggested by the imaging description provided.

  • His upper abdominal pain in the context of obesity and PPI use for reflux strongly suggests a GI etiology (GERD, peptic ulcer disease, gastritis, or PPI-related mucosal changes). 2, 3, 4

What You Must Do Next: Comprehensive Workup Required

Despite being unrelated to his pain, this 4.1 cm adrenal mass requires a complete functional and radiologic evaluation. 1

Step 1: Obtain Non-Contrast CT Characteristics

  • If the initial CT was contrast-enhanced, you need a dedicated non-contrast CT to measure Hounsfield Units (HU). 1
  • Masses <10 HU are benign lipid-rich adenomas; masses >10 HU require further characterization with either washout CT or chemical-shift MRI. 1
  • Be aware that approximately one-third of adenomas don't washout in the typical benign range, and one-third of pheochromocytomas can mimic adenomas on washout studies. 1

Step 2: Screen for Hormone Hypersecretion (Mandatory for All)

All patients with adrenal incidentalomas require functional testing regardless of imaging characteristics or symptoms. 1

Cortisol Screening (Everyone Gets This):

  • Perform 1 mg dexamethasone suppression test on all patients with adrenal incidentalomas. 1
  • Look for signs of Cushing's syndrome on history/physical: central obesity, easy bruising, proximal muscle weakness, wide purple striae, facial plethora. 1

Pheochromocytoma Screening:

  • If the mass is >10 HU on non-contrast CT OR if he has any symptoms of catecholamine excess (headaches, palpitations, sweating, anxiety), screen with plasma or 24-hour urinary metanephrines. 1
  • You can skip pheochromocytoma screening ONLY if the mass is definitively <10 HU and he has zero adrenergic symptoms. 1

Aldosterone Screening (If Indicated):

  • Screen for primary aldosteronism with aldosterone-to-renin ratio if he has hypertension or hypokalemia. 1

Step 3: Size-Based Management

Because this mass is ≥4 cm, even if radiologically benign and non-functional, it requires repeat imaging in 6-12 months. 1

  • Adrenalectomy should be considered if the mass grows >5 mm/year on follow-up, after repeating functional workup. 1
  • If growth is <3 mm/year, no further imaging or functional testing is needed. 1
  • Shared decision-making is appropriate for indeterminate non-functional lesions, with options including repeat imaging in 3-6 months versus surgical resection. 1

Step 4: Multidisciplinary Review

Maintain a low threshold for multidisciplinary discussion with endocrinology, surgery, and radiology when imaging is indeterminate, hormone hypersecretion is detected, or the mass grows significantly. 1

Address His Actual Pain

Focus your diagnostic efforts on his upper GI symptoms:

  • Reassess adequacy of his PPI therapy and consider endoscopy if symptoms are refractory or alarm features are present. 3, 4
  • Long-term PPI use can cause gastric mucosal changes (fundic gland polyps, hyperplastic polyps) but these are generally benign. 2
  • His obesity may affect PPI pharmacokinetics, potentially requiring dose adjustment. 5
  • Rule out other causes: peptic ulcer disease, gastritis, biliary pathology, or pancreatic disease.

Critical Pitfall to Avoid

Do not attribute his pain to the adrenal mass and delay appropriate GI evaluation. This is a common error that can lead to missed diagnoses of treatable upper GI pathology while pursuing unnecessary adrenal interventions. The adrenal finding is coincidental and requires its own systematic workup independent of his pain syndrome.

Related Questions

In an older adult with gastric angiodysplasia, is proton pump inhibitor therapy required for lesion healing?
What are the treatment options for a 69-year-old female patient with uncontrolled Gastroesophageal Reflux Disease (GERD) symptoms, duodenal diverticulum versus duodenal ulcer, geographic fatty infiltration of the liver, atherosclerosis, obstipation of the colon, and a small hiatal hernia?
What is the best Proton Pump Inhibitor (PPI) for a 7-year-old female (F) patient with Gastroesophageal Reflux Disease (GERD)?
Should I increase pantoprazole to BID or change to a different PPI for a 91 YOF with recalcitrant GERD?
How should I manage a 49‑year‑old perimenopausal woman with 2‑month amenorrhea, mild transaminitis, toe‑nail onychomycosis, an acute upper‑respiratory infection causing cough, clear nasal discharge, itchy throat, and intermittent gastro‑esophageal reflux, who is currently taking cetirizine and zinc but not a proton‑pump inhibitor and is considering a higher PPI dose?
What is the recommended dosing regimen of Estrace (estradiol vaginal cream 0.01%) for treating vaginal dryness in a postmenopausal woman?
How can I differentiate communicating from obstructive hydrocephalus and what are the appropriate diagnostic and treatment approaches for each?
Can you explain emphysema in simple terms suitable for patient education?
I have a thyroid peroxidase antibody level of 40 IU/mL and a TSH of 6.4 mIU/L; what does this indicate and how should it be managed?
What is the recommended staging work‑up and treatment plan for a patient with a biopsy‑proven invasive ductal carcinoma showing focal comedo necrosis, high nuclear grade, solid and cribriform pattern, and calcifications?
What is the normal opening pressure measured during a lumbar puncture in patients with normal‑pressure hydrocephalus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.